Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.07. | NSE - QT IMAGING HOLDINGS, INC. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
12.06. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
21.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.05. | QT Imaging Holdings GAAP EPS of -$0.40, revenue of $2.8M | 1 | Seeking Alpha | ||
13.05. | QT Imaging announces $200,000 PIPE investment | 2 | Seeking Alpha | ||
13.05. | QT IMAGING HOLDINGS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
QT IMAGING Aktie jetzt für 0€ handeln | |||||
13.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
23.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
10.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
31.03. | QT Imaging Holdings GAAP EPS of -$0.15 | 1 | Seeking Alpha | ||
31.03. | QT IMAGING HOLDINGS, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
31.03. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
28.02. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
27.02. | QT Imaging receives $10.1M in new funding | 1 | Seeking Alpha | ||
12.02. | QT IMAGING HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
05.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.02.2025 | 985 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.02.2025ISIN NameCA75525M1095 RAZOR... ► Artikel lesen | |
13.11.24 | QT Imaging Announces Third Quarter 2024 Financial Results | 220 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen | |
08.08.24 | QT Imaging Announces Second Quarter 2024 Financial Results | 264 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
INTUITIVE SURGICAL | 408,05 | -0,99 % | Intuitive Surgical Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,117 | -3,31 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,716 | +2,58 % | RedChip Companies, Inc.: Atossa Therapeutics and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | ORLANDO, FL / ACCESS Newswire / August 1, 2025 / RedChip Companies will air interviews with Calidi Biotherapeutics, Inc. (NYSE American:CLDI) and Atossa Therapeutics, Inc. (Nasdaq:ATOS) on the RedChip... ► Artikel lesen | |
PING AN HEALTHCARE | 1,320 | -0,34 % | PA GOODDOCTOR (01833): NOTICE OF BOARD MEETING | ||
MOUNTAIN VALLEY MD | 0,006 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,212 | 0,00 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
CYTOSORBENTS | 0,787 | -1,50 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
VERU | 0,321 | -16,86 % | Veru Inc.: Veru Announces Reverse Stock Split | MIAMI, FL, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
VOLITIONRX | 0,613 | 0,00 % | VolitionRx prices $1.2M registered direct offering | ||
EKSO BIONICS | 3,230 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 7,330 | -2,27 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.08.2025 | Das Instrument 9YG NO0010955917 DEEP VAL.DRILL.AS NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 06.08.2025 und ex Kapitalmassnahme am 07.08.2025 The instrument 9YG NO0010955917 DEEP VAL.DRILL.AS... ► Artikel lesen | |
BEYOND AIR | 2,790 | 0,00 % | Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. | GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
AROVELLA THERAPEUTICS | 0,051 | -12,17 % | AROVELLA THERAPEUTICS LIMITED: Notice Under Section 708A |